ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

First- and Second-Year Outcomes After Nirsevimab Immunization

Study limitation reported by the research below: “The associations with ENT bacterial infections and asthma hospitalizations in year 2 are observational and may be confounded by differential healthcare-seeking behavior or unmeasured factors; causality cannot be established.”

Papers